Your browser doesn't support javascript.
loading
Safety and Efficacy of Camrelizumab in Combination With Nab-Paclitaxel Plus S-1 for the Treatment of Gastric Cancer With Serosal Invasion.
Lin, Ju-Li; Lin, Jian-Xian; Lin, Jun Peng; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun; Chen, Qi-Yue; Huang, Chang-Ming.
Afiliación
  • Lin JL; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Lin JX; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Lin JP; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Zheng CH; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Li P; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Xie JW; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Wang JB; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Lu J; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Chen QY; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Huang CM; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Front Immunol ; 12: 783243, 2021.
Article en En | MEDLINE | ID: mdl-35116023

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza